Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Baudin

Showing results (161-170 of 241) with videos related to

Pageof 25
Sort By:
Advances in Therapy|April 14, 2022
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE StudyDenis Smith, Côme Lepage, Eric Vicaut, et al.
Neuroendocrinology|August 21, 2019
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine TumoursAnna Pellat, Thomas Walter, Jérémy Augustin, et al.
The International Journal of Biological Markers|May 17, 2011
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up studyDelphine Vezzosi, Thomas Walter, Agnès Laplanche, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2012
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomasMontserrat Ayala-Ramirez, Cecile N Chougnet, Mouhammed Amir Habra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007Eric Lim, Peter Goldstraw, Andrew G Nicholson, et al.
Endocrine|January 7, 2018
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytomaGuillaume Gravel, Sophie Leboulleux, Lambros Tselikas, et al.
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2021
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane TherapyDeborah Cosentini, Salvatore Grisanti, Julien Hadoux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trialSamuel A Wells, Bruce G Robinson, Robert F Gagel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
Pageof 25

Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Advances in Therapy|April 14, 2022
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE StudyDenis Smith, Côme Lepage, Eric Vicaut, et al.
Neuroendocrinology|August 21, 2019
Chemotherapy in Resected Neuroendocrine Carcinomas of the Digestive Tract: A National Study from the French Group of Endocrine TumoursAnna Pellat, Thomas Walter, Jérémy Augustin, et al.
The International Journal of Biological Markers|May 17, 2011
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up studyDelphine Vezzosi, Thomas Walter, Agnès Laplanche, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2012
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomasMontserrat Ayala-Ramirez, Cecile N Chougnet, Mouhammed Amir Habra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007Eric Lim, Peter Goldstraw, Andrew G Nicholson, et al.
Endocrine|January 7, 2018
Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytomaGuillaume Gravel, Sophie Leboulleux, Lambros Tselikas, et al.
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2021
Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane TherapyDeborah Cosentini, Salvatore Grisanti, Julien Hadoux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trialSamuel A Wells, Bruce G Robinson, Robert F Gagel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN NetworkAurelien Fosse, Julien Hadoux, Paul Girot, et al.
Pageof 25